Using artificial intelligence to discover therapeutic antibodies
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advan…
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advan…
Pushing the limits For a long time, the diffraction limit defined by Ernst Abbe described a natural barrier limiting…
Schaeffler Gruppe steigert Umsatz währungsbereinigt um 9,4 Prozent auf 15,8 Milliarden Euro EBIT vor Sondereffekten von…
. Schaeffler Gruppe steigert Umsatz währungsbereinigt um 9,7 Prozent EBIT-Marge vor Sondereffekten 9,1 Prozent (nach 6…
Expansion includes acquisition of novel, high-resolution cryo-electron microscope – with micro electron diffraction (mic…
Founded in 2002 and based in Strasbourg, France, NovAliX is a drug discovery-focused CRO with several unique technologie…
Deutliche Verbesserung des CDP-Klimaratings von „D“ auf „A-“ Maßnahmen zur Steigerung der Ressourcen- und Energieeffizie…
ibidi is pleased to announce that their CEOs, Dr. Valentin Kahl and Dr. Roman Zantl, have been recognized together in th…
Bruker today announced the release of the NanoRacer high-speed AFM system. With an unprecedented imaging speed of 50 fra…
Bruker gab heute die Markteinführung des NanoRacer High-Speed-AFM-Systems bekannt. Mit einer beispiellosen Abbildungsges…